- Report
- September 2024
- 86 Pages
Global
From €3500EUR$4,239USD£3,123GBP
- Report
- August 2024
- 107 Pages
Global
From €3500EUR$4,239USD£3,123GBP
- Report
- October 2023
- 131 Pages
Global
From €3500EUR$4,239USD£3,123GBP
- Report
- October 2023
- 124 Pages
Global
From €3500EUR$4,239USD£3,123GBP
- Report
- March 2024
- 98 Pages
Global
From €3500EUR$4,239USD£3,123GBP
- Report
- November 2023
- 93 Pages
Global
From €3500EUR$4,239USD£3,123GBP
- Report
- March 2022
- 94 Pages
Global
From €3500EUR$4,239USD£3,123GBP
- Report
- March 2024
- 132 Pages
Global
From €840EUR$950USD£724GBP
- Report
- March 2024
- 132 Pages
Global
From €840EUR$950USD£724GBP
- Book
- June 2020
- 198 Pages
- Report
- November 2021
- 527 Pages
Global
From €3538EUR$4,000USD£3,050GBP
- Report
- November 2021
- 545 Pages
Global
From €3538EUR$4,000USD£3,050GBP
- Report
- November 2021
- 802 Pages
Global
From €4423EUR$5,000USD£3,813GBP
- Report
- November 2021
- 233 Pages
Global
From €2211EUR$2,500USD£1,906GBP
- Report
- November 2021
- 1165 Pages
Global
From €5307EUR$6,000USD£4,576GBP
- Report
- November 2021
- 1184 Pages
Global
From €5307EUR$6,000USD£4,576GBP
- Book
- May 2022
- 512 Pages
- Book
- March 2022
- 896 Pages
- Book
- October 2020
- 288 Pages

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools.
Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more